Nomura Holdings, Inc.
NYSE:NMRFinancial - Capital Markets
-$0.12 today
- Market cap
- $27.29B
- Beta
- 0.61
- P/E (TTM)
- 0.3
- EPS (TTM)
- $4,986.67
- Dividend yield
- 3.55%
Volume 3.51M
Average 1.75M
NMR Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Nomura Holdings, Inc.NYSE: NMR
Depreciation & Amortization · Q4 FY2026 · quarter ended Mar 2026
Depreciation & amortization outflow grows to ¥19.39B
Q4 FY2026 depreciation & amortization was ¥19.39B, compared with ¥0 a year earlier. Trailing-twelve-month depreciation & amortization was ¥19.39B. Over 3 fiscal years it compounded at +3.6% a year.
Context
- Depreciation & amortization amounted to 1.4% of revenue in FY2026, unchanged from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly depreciation & amortization holds near ¥19.39B or moves back toward the trailing-twelve-month quarterly average of ¥4.85B.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
JPY · from the cash flow
- Latest · FY2026
- 68.27B JPY
- Year-over-year change
- +10.7%
- 4-year CAGR
- +3.5%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 68.27B | +10.7% |
| FY2025 | 2025-03-31 | 61.65B | +0.5% |
| FY2024 | 2024-03-31 | 61.34B | -0.1% |
| FY2023 | 2023-03-31 | 61.42B | +3.2% |
| FY2022 | 2022-03-31 | 59.52B | — |
Depreciation & Amortization vs competitors
How NMR compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Depreciation & amortization amounts to 0.4% of revenue for NMR, versus a peer median of 2.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | ¥19.39B JPY | — | +3.6% | 0.4% | |
| LTM Mar 2026 | $3.38B USD | -10.2% | +19.6% | 4.5% | |
| LTM Sep 2026 | $3.05B USD | -40.9% | +5.2% | 2.4% | |
| LTM Jun 2026 | $2.06B USD | -8.1% | -3.9% | 1.7% | |
| LTM Aug 2026 | $192.53M USD | -4.1% | +2.2% | 1.5% | |
| LTM Jun 2026 | $157.46M USD | +89.8% | +10.7% | 2.4% | |
| LTM Mar 2026 | $37.85M USD | +1.3% | +3.1% | 2.2% | |
| LTM Sep 2026 | $31.2M USD | -9.2% | -30.8% | 0.9% | |
| LTM Jun 2026 | $26.87M USD | +208.7% | -28.4% | 0.6% | |
| Peer median (excluding NMR) | — | -6.1% | +2.6% | 2.0% | |
Competitors are the stored peer set for NMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Net Income | 146.53B | 91.68B | 177.22B | 347.26B | 374.38B |
| Depreciation & Amortization | 59.52B | 61.42B | 61.34B | 61.65B | 68.27B |
| Deferred Income Tax | 3.11B | 6.14B | (312M) | 11.56B | 0 |
| Stock-Based Compensation | 27.94B | 35.22B | 51.51B | 38.58B | 0 |
| Change in Working Capital | (874.99B) | (453.66B) | (116.12B) | (1.11T) | (1.23T) |
| Accounts Receivables | 0 | 0 | 0 | 0 | (653.33B) |
| Inventory | 0 | 0 | 0 | 0 | (2.86T) |
| Accounts Payables | (247.98B) | (139.42B) | 709.84B | 0 | 1.81T |
| Other Working Capital | (627.01B) | (314.25B) | (825.95B) | (1.11T) | 474.21B |
| Other Non-Cash Items | (224.95B) | (435.61B) | (41.01B) | (25.47B) | (59.57B) |
| Operating Cash Flow | (862.83B) | (694.82B) | 132.64B | (678.61B) | (842.96B) |
| Capital Expenditures | (111.33B) | (171.17B) | (145.78B) | (189.97B) | (353.82B) |
| Acquisitions (Net) | 0 | 16.95B | (457M) | 8.14B | (275B) |
| Purchases of Investments | (115.21B) | (75.5B) | (156.93B) | (322.45B) | (8.9T) |
| Sales of Investments | 205.53B | 301.07B | 177.09B | 154.39B | 7.95T |
| Other Investing Activities | (572.17B) | (304.58B) | (761.85B) | (498.76B) | (151.66B) |
| Investing Cash Flow | (593.18B) | (233.23B) | (887.94B) | (848.65B) | (1.5T) |
| Debt Repayment | 861.78B | 1.02T | 1.03T | 1.1T | 1.55T |
| Common Stock Issued | 11M | 4M | 953M | 1.41B | 422M |
| Common Stock Repurchased | (39.65B) | (24.73B) | (61.03B) | (59.01B) | (101.5B) |
| Dividends Paid | (70.71B) | (57.26B) | (60.16B) | (112.54B) | (179.74B) |
| Other Financing Activities | 361.29B | 341.9B | 116.79B | 748.75B | 828.23B |
| Financing Cash Flow | 1.11T | 1.28T | 1.01T | 1.68T | 2.1T |
| Effect of Forex Changes | 149.69B | 148.55B | 220.62B | (26.02B) | 139.31B |
| Net Change in Cash | (193.6B) | 504.44B | 478.17B | 126.42B | (106.72B) |
| Free Cash Flow | (974.16B) | (865.99B) | (13.14B) | (868.58B) | (1.2T) |
Nomura Holdings, Inc.
NYSE:NMR
Intrinsic Alpha fair value
Locked
Current Price
$9.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.